Russia to Introduce State Control over Tobacco Industry

Mar.10.2023
Russia to Introduce State Control over Tobacco Industry
Russia introduces alcohol-like regulations for tobacco industry, including production permits and criminal liability for violations.

On March 8th, according to Russian media outlet RG.RU, the tobacco industry in Russia will introduce national control measures similar to those for alcohol, including production permits, a unified information system and criminal liability for violations. The proposed legislation from the Ministry of Finance will be discussed at a government meeting on March 9th.


According to the Ministry of Finance, the purpose of this bill is to introduce a comprehensive national regulatory system to manage the tobacco industry. This type of regulatory model has already been applied in the alcohol market. Currently, there are problems with management in the Russian cigarette market, with one out of every seven packs of cigarettes sold being illegal. Therefore, the government plans to tighten regulations in this industry.


A new bill is requiring licenses for the production and import of tobacco, nicotine-containing products, and their raw materials. Additionally, producers are obligated to register their main equipment for manufacturing these products. If unused, the equipment must be sealed. Equipment used in illegal production will be confiscated. All product and material records will be tracked through the "Honest Label" tagging system, ensuring comprehensive government regulation, according to the Ministry of Finance's explanation.


The bill also includes other measures to prevent illegal production and trade: prohibiting the sale of tobacco products and nicotine-containing products in non-consumer packaging, and requiring the presence of accompanying documents and labeling in their transactions. "The implementation of this bill will help reduce the circulation of illegal tobacco and nicotine-containing products," the department believes. Meanwhile, experts believe that in addition to production, retail also needs license control, as the share of illegal tobacco products has increased 12 times in the past eight years.


According to data from the Ministry of Industry and Trade, the illegal tobacco trade in just the first nine months of last year resulted in a loss of 61.6 billion rubles (approximately 5.6 billion yuan) to the budget. One of the reasons for the increase in illegal tobacco trade is the incomplete legal reforms.


Sergey Ryabukhin, the First Deputy Chairman of the Budget and Financial Markets Committee of the Russian Federation Council, believes that long-prepared regulatory measures have become urgent. He thinks that national regulation of the tobacco industry would help monitor the quality of tobacco products.


However, industry experts have criticized the bill. For example, Pavel Shapkin, chairman of the National Consumer Rights Protection Union and head of the National Center for Alcohol Policy Development, believes that a license system should be implemented for the retail sale of tobacco. He believes that licensing does not eliminate the possibility of illegal products being sold at the retail level. Dimitriy Vlakhmiriov, chairman of the Tobacco and Nicotine Product Joint Enterprise Association, pointed out that the bill only applies to nicotine-containing products.


Riyabukhin believes that the proposed bill should be passed as soon as possible, with further improvements to be made based on practical experience. The next step should be to coordinate tax rates across the entire Eurasian Economic Union (EAEU) to combat illicit tobacco products.


References:


The Russian Ministry of Finance has introduced a bill to regulate the tobacco industry under state supervision.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
Product | BAT Expands VELO Travellers’ Collection With Mexico, Spain and Sweden Summer Edition Nicotine Pouches
Product | BAT Expands VELO Travellers’ Collection With Mexico, Spain and Sweden Summer Edition Nicotine Pouches
British American Tobacco (BAT) Global Travel Retail has expanded the VELO Travellers’ Collection with three new Summer Editions: Mexico, Spain and Sweden. Inspired by destination themes, the new nicotine pouch variants are designed for global travel-retail channels. The launch further strengthens VELO’s positioning as a travel-retail exclusive product collection.
Aug.27
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives